Leukemia, Myeloid, Acute

<section class="Section" data-sectioncode="34089-3"><a name="s11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Olutasidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor. The chemical name is (S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile. The chemical structure is:</p><p><img alt="chemical structure" src="struct-01.jpg"/></p><p>The molecular formula is C<span class="Sub">18</span>H<span class="Sub">15</span>ClN<span class="Sub">4</span>O<span class="Sub">2</span> and the molecular weight is 354.79 g/mol. Olutasidenib is a white to off-white to brown powder that is practically insoluble in aqueous solutions between pH 1.2 and 7.4.</p><p>REZLIDHIA (olutasidenib) is available as hard gelatin capsules for oral administration. Each capsule contains 150 mg olutasidenib and the following ingredients: croscarmellose sodium, magnesium stearate and microcrystalline cellulose. The capsule shell contains gelatin and titanium dioxide. Each capsule is printed with black ink containing ferrosoferric oxide, propylene glycol, and shellac.</p></section>

REZLIDHIA

olutasidenib

olutasidenib 150 MG Oral Capsule

Rezlidhia

olutasidenib 150 MG Oral Capsule [Rezlidhia]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event 

Submit MSL Request 

Prescribing Information 

Medication Guide 

Pharmacy List 

How To Order Rezlidhia 

Coverage Authorization Request 

Coverage Authorization Appeals 

Rezlidhia Enrollment Form

Enroll in Patient Savings Program 

Differentiation Syndrome Pocket Reference

Getting Started with Rezlidhia 

Instructions For Use: R/R IDH1+ Acute Myeloid Leukemia 